Skip to content

5 Pharma Procurement Challenges (and How Leading Teams Solve Them)

by ZAGENO
 | 1 min read
scientist in lab holding her head from procurement challenges

Pharma procurement sits at the intersection of scientific research, rigorous compliance, and complex global supply chains. Unlike traditional purchasing, it must support highly specialized workflows while maintaining strict GxP standards and cost control.

When procurement is fragmented, it does more than just inflate costs. It creates bottlenecks that delay research timelines and introduce audit risks. This guide breaks down the key pharma procurement challenges and how leading teams are addressing them.

The 5 biggest pharma procurement challenges

  1. Supplier fragmentation and supplier sprawl

    Pharmaceutical organizations often rely on thousands of niche suppliers. While this variety is critical to support specialized research, it creates immense operational complexity.

    Supplier fragmentation leads to:

    • Inconsistent pricing across different research teams.
    • Duplicate suppliers for identical or similar products.
    • Administrative burden from managing too many individual accounts.
    • Limited visibility into the organization's total spend.

    Over time, this lack of coordination reduces procurement efficiency and weakens supplier strategy.

    Strategy link: Learn how to implement a supplier consolidation strategy for lab procurement.

  2. Lack of centralized spend visibility

    In many pharma organizations, data is siloed across various spreadsheets, vendor portals, and legacy systems. McKinsey & Company research indicates that these supply chain inefficiencies can inflate operational costs by as much as 30%, a significant burden that diverts resources away from actual R&D.

    Without real-time, organization-wide visibility, procurement teams cannot easily:

    • Enforce preferred supplier strategies.
    • Identify high-impact cost-saving opportunities.
    • Align purchasing behavior with overarching research priorities.
    Operational insight: Improving visibility requires centralized workflows, integrated reporting, and AI-driven insights that highlight patterns and inefficiencies across procurement data. See how to improve lab spend management in R&D.

  3. Compliance and audit risk

    Pharma procurement must operate within strict regulatory frameworks, including GxP requirements and audit-ready documentation standards. The International Society for Pharmaceutical Engineering (ISPE) emphasizes that structured systems are vital to ensuring compliance in these environments.

    When systems are manual or decentralized, teams face an increased risk of:

    • Audit failures due to incomplete documentation.
    • Inconsistent supplier vetting and qualification records.
    • Lack of product traceability.
    Leading teams reduce this risk by embedding compliance directly into procurement workflows through centralized systems and automated audit trails.

  4. Procurement and research misalignment

    A natural tension often exists: procurement teams focus on governance and cost, while scientists prioritize speed and precision. If procurement systems are too rigid, researchers may bypass them, leading to maverick spend and broken supplier strategies.

    Modern pharma organizations solve this by designing workflows that support how scientists actually work, making it easy to stay compliant without slowing down the lab.

    One of the most effective approaches is guided buying, which structures the purchasing experience so researchers are directed toward preferred suppliers, compliant products, and approved workflows by default. Instead of enforcing rigid controls, guided buying reduces friction while ensuring procurement policies are followed in practice.

  5. Supply chain risk and global disruptions

    Global sourcing introduces volatility. According to organizations like the World Health Organization, limited sourcing diversity is a primary driver of global medicine shortages. Reliance on a narrow set of suppliers can lead to:

    • Backorders and supply interruptions.
    • Delayed experiments and clinical timelines.
    Leading teams mitigate this by taking an active role in supplier diversification and risk management

How leading pharma teams solve these challenges

Pharmaceutical leaders are moving away from fragmented purchasing and toward a centralized pharma procurement strategy.

Single entry point

Unifying access into a single environment that brings catalog and non-catalog spend into one system.

Real-time visibility

Using live data to track purchasing patterns and control costs.

Integrated workflows

Connecting procurement platforms with ERP and finance tools for seamless reconciliation.

Built-in compliance

Automating audit trails to ensure readiness without extra administrative work.

Guided buying

Structuring the purchasing experience so scientists are automatically guided toward preferred suppliers, compliant products, and approved workflows, reducing maverick spend without limiting choice.

AI-driven insights

Leveraging AI to highlight better supplier options, identify cost-saving opportunities, and enable faster, more informed purchasing decisions.

Why modernizing procurement is a strategic priority

Efficient procurement is no longer just a back-office function; it is a core driver of R&D success. Organizations that solve these challenges are able to:

  • Accelerate research by removing purchasing bottlenecks.
  • Improve supplier performance and resilience.
  • Gain full visibility into every dollar spent.
ZAGENO website homepage on laptop and mobile device

Take the next step

ZAGENO helps pharmaceutical teams reduce complexity and manage procurement at scale. Ready to bridge the gap between research and procurement?

Request a demo

Frequently asked questions about pharma procurement challenges

  1. What are the biggest challenges in pharma procurement?
    The biggest challenges include supplier fragmentation, lack of visibility, compliance requirements, manual workflows, and supply chain risk.
  2. Why is pharma procurement more complex than other industries?
    Pharma procurement must balance regulatory compliance, scientific precision, and global supplier networks, making it significantly more complex than traditional purchasing.
  3. How do pharma companies manage supplier fragmentation?
    They centralize procurement processes and implement supplier consolidation strategies while maintaining access to specialized products.
  4. What causes poor visibility in pharma procurement?
    Decentralized purchasing, disconnected systems, and lack of integrated reporting tools limit visibility into spend and supplier performance.
  5. How can pharma procurement be improved?
    Pharma procurement improves through centralized workflows, better data visibility, integrated systems, and embedded compliance processes.

All your lab needs in one place

Access 50,000,000 products in one shop!

Trusted by thousands of scientists, lab managers, procurement and finance teams, ZAGENO's marketplace will help you search and order quickly in one go. Reach out for a demo today!